Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1989-7-20
|
| pubmed:abstractText |
The effect of high-dose medroxyprogesterone acetate was studied in 7 patients with advanced prostatic cancer. Results in 7 patients were no change (NC) in 5 (71%) and progressive disease (PD) in 2 patients (29%). However, pain relief was obtained in 6 of the 7 patients (86%). As side effects, 2 patients (29%) showed moon-face and 2 patients weight gain (29%). These results indicate that treatment of high-dose medroxyprogesterone acetate is useful for pain relief in patients with advanced prostatic cancer.
|
| pubmed:language |
jpn
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0018-1994
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
35
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
603-8
|
| pubmed:dateRevised |
2009-11-19
|
| pubmed:meshHeading |
pubmed-meshheading:2525316-Adenocarcinoma,
pubmed-meshheading:2525316-Administration, Oral,
pubmed-meshheading:2525316-Aged,
pubmed-meshheading:2525316-Antineoplastic Agents,
pubmed-meshheading:2525316-Humans,
pubmed-meshheading:2525316-Male,
pubmed-meshheading:2525316-Medroxyprogesterone,
pubmed-meshheading:2525316-Medroxyprogesterone Acetate,
pubmed-meshheading:2525316-Middle Aged,
pubmed-meshheading:2525316-Pain, Intractable,
pubmed-meshheading:2525316-Prostatic Neoplasms
|
| pubmed:year |
1989
|
| pubmed:articleTitle |
[Pain relief by high-dose medroxyprogesterone acetate in advanced prostatic cancer].
|
| pubmed:affiliation |
Department of Urology, Faculty of Medicine, Toyama Medical and Pharmaceutical University.
|
| pubmed:publicationType |
Journal Article,
English Abstract
|